Moreover, a low dose of warfarin below the anticoagulant dosage, effectively blocks γ‐carboxylation of the Gla domain of PRRG1, reverses its regulation on KRAS and EGFR, and PDAC in vivo tumour growth. Here, PRRG1 is linked to neoplasm.